PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24977650-4	2014	All patients receiving G-CSF and plerixafor had generally poor CD34(+) cell and Lin(-) CD34(+) CD38(-) CD90(+) CD45RA(-) HSC mobilization, and developed donor T cells, but no donor myeloid or B-cell engraftment.	plerixafor	33-43	CD38 molecule	Homo sapiens	95-99	
26018461-8	2015	RESULTS: Blood grafts in the plerixafor group contained a significantly higher proportion of CD34+133+CD38- cells and more lymphocytes of all major subsets except B lymphocytes.	plerixafor	29-39	CD38 molecule	Homo sapiens	102-106	
22536949-10	2012	RESULTS: The proportion of primitive stem cells (CD34(+)  CD133(+)  CD38(-) ) was significantly higher after the plerixafor injection when compared to the first collection in the control group.	plerixafor	113-123	CD38 molecule	Homo sapiens	68-72	
24673458-4	2014	The phenotype of CD34+ HCs collected after this plerixafor-induced "rescue" mobilization, in regard to adhesion molecule and CD133, CD34, and CD38 expression in comparison to CD34+ HCs collected after traditional G-CSF administration in good mobilizers, was analyzed flow cytometrically.	plerixafor	48-58	CD38 molecule	Homo sapiens	142-146	
24673458-6	2014	RESULTS: Pronounced mobilization occurred after plerixafor administration in poor mobilizers, resulting in similar CD34+ cell yields as obtained by G-CSF in good mobilizers, whereby plerixafor increased the content of primitive CD133+/CD34+/CD38- cells.	plerixafor	182-192	CD38 molecule	Homo sapiens	241-245	
24128272-10	2014	In contrast, PB CD34+CD38- concentrations significantly increased from 10 to 18 hours after plerixafor (p = 0.03).	plerixafor	92-102	CD38 molecule	Homo sapiens	21-25	
22897584-7	2013	RESULTS: The proportion of the most primitive stem cells (CD34+CD133+CD38-) from all CD34+ cells in the graft was higher in the plerixafor-treated patients but there was no significant difference in the total number of these cells.	plerixafor	128-138	CD38 molecule	Homo sapiens	69-73	
21077729-6	2011	RESULTS: The number of aldehyde dehydrogenase (ALDH)(bright) and CD34(+) cells was significantly higher after plerixafor treatment (1.2-5.0 and 1.5-6.0 times; both P < 0.01) and an enrichment of the very primitive CD34(+) CD38(-) and ALDH(bright) CD34(+) CD38(-) HSC subsets was detectable.	plerixafor	110-120	CD38 molecule	Homo sapiens	225-229	
21077729-6	2011	RESULTS: The number of aldehyde dehydrogenase (ALDH)(bright) and CD34(+) cells was significantly higher after plerixafor treatment (1.2-5.0 and 1.5-6.0 times; both P < 0.01) and an enrichment of the very primitive CD34(+) CD38(-) and ALDH(bright) CD34(+) CD38(-) HSC subsets was detectable.	plerixafor	110-120	CD38 molecule	Homo sapiens	258-262